RANDOMIZED, OPEN CLINICAL TRIAL TO EVALUATE BLADDER INSTILATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL BLADDER RESECTION FOR THE PREVENTION OF RECURRENCE OF NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA.
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: MARTÍNEZ-PIÑEIRO
- Phase: IV
- Execution start: 29/03/2022
- End of execution: 31/12/2029
- IP: MIGUEL ARRABAL MARTIN
